Celldex Therapeutics, Inc. Earnings Per Share, Basic in USD/shares from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Celldex Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to Q3 2025.
  • Celldex Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -1.01 USD/shares, a 57.8% decline year-over-year.
  • Celldex Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -3 USD/shares, a 31% decline year-over-year.
  • Celldex Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -2.45 USD/shares, a 16.1% increase from 2023.
  • Celldex Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.92 USD/shares, a 21.7% decline from 2022.
  • Celldex Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.4 USD/shares, a 46.3% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Celldex Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$3 -$1 $0 -57.8% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 -$3 -$1 $0 -57.4% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$2 -$1 $0 -44.6% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 -$2 -$1 +$0.13 +15.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 -$2 -$1 +$0.17 +21% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 -$2 -$1 +$0.11 +16.9% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$2 -$1 +$0.06 +9.68% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 -$2 -$1 $0 -47.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 -$2 -$1 $0 -42.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$2 -$1 +$0.12 +15.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$2 -$1 $0 -26.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 -$2 -$1 $0 -32.6% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 -$2 -$1 $0 -26.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$2 -$1 $0 -126% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$1 $0 $0 -16.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$1 $0 Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05

Celldex Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2 +$0.47 +16.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$3 -$1 -21.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$2 -$1 -46.3% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 -$2 +$0.38 +18.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 -$2 +$1.49 +42.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$4 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.